JAZZ vs SW · P/E 1988, rev $2.28B vs P/E 59, rev $31.18B
Jazz Pharmaceuticals PLC (JAZZ) versus Smurfit WestRock plc (SW) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Smurfit WestRock plc (SW) is a packaging & containers company listed on US.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported SW revenue for 2025-12-31 was $31.18B. Net income was $699.0M. Revenue was up 47.7% from 2024-12-31 to 2025-12-31. SW currently screens at market cap $22.09B and trailing P/E 58.5.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. SW currently screens at market cap $22.09B and trailing P/E 58.5.
Not investment advice. Open the JAZZ and SW stock pages for the full models.
Not investment advice.